X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT vs PANACEA BIOTECH - Comparison Results

WOCKHARDT    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT PANACEA BIOTECH WOCKHARDT/
PANACEA BIOTECH
 
P/E (TTM) x -14.0 -7.3 - View Chart
P/BV x 1.6 3.9 42.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 WOCKHARDT   PANACEA BIOTECH
EQUITY SHARE DATA
    WOCKHARDT
Mar-18
PANACEA BIOTECH
Mar-18
WOCKHARDT/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,012364 278.0%   
Low Rs532129 411.7%   
Sales per share (Unadj.) Rs355.996.8 367.7%  
Earnings per share (Unadj.) Rs-60.3-12.4 485.8%  
Cash flow per share (Unadj.) Rs-46.8-2.9 1,639.5%  
Dividends per share (Unadj.) Rs0.010-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs257.850.4 511.5%  
Shares outstanding (eoy) m110.6361.25 180.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.22.5 85.1%   
Avg P/E ratio x-12.8-19.9 64.4%  
P/CF ratio (eoy) x-16.5-86.4 19.1%  
Price / Book Value ratio x3.04.9 61.2%  
Dividend payout %00-   
Avg Mkt Cap Rs m85,37915,101 565.4%   
No. of employees `0006.32.5 253.4%   
Total wages/salary Rs m9,3711,516 618.2%   
Avg. sales/employee Rs Th6,295.02,401.9 262.1%   
Avg. wages/employee Rs Th1,498.3614.2 243.9%   
Avg. net profit/employee Rs Th-1,066.3-307.9 346.3%   
INCOME DATA
Net Sales Rs m39,3695,928 664.1%  
Other income Rs m1,20282 1,460.9%   
Total revenues Rs m40,5716,010 675.0%   
Gross profit Rs m18845 2.2%  
Depreciation Rs m1,495585 255.5%   
Interest Rs m2,5551,006 254.0%   
Profit before tax Rs m-2,830-664 426.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m02 0.0%   
Extraordinary Inc (Exp) Rs m-3,5820-   
Tax Rs m25799 260.6%   
Profit after tax Rs m-6,669-760 877.4%  
Gross profit margin %014.3 0.3%  
Effective tax rate %-9.1-14.9 61.1%   
Net profit margin %-16.9-12.8 132.1%  
BALANCE SHEET DATA
Current assets Rs m33,7965,603 603.1%   
Current liabilities Rs m26,9176,910 389.5%   
Net working cap to sales %17.5-22.0 -79.3%  
Current ratio x1.30.8 154.8%  
Inventory Days Days79206 38.6%  
Debtors Days Days8984 106.6%  
Net fixed assets Rs m39,6649,941 399.0%   
Share capital Rs m55361 902.4%   
"Free" reserves Rs m27,9683,026 924.4%   
Net worth Rs m28,5223,087 924.0%   
Long term debt Rs m21,7315,707 380.8%   
Total assets Rs m81,62016,076 507.7%  
Interest coverage x-0.10.3 -31.6%   
Debt to equity ratio x0.81.8 41.2%  
Sales to assets ratio x0.50.4 130.8%   
Return on assets %-5.01.5 -329.6%  
Return on equity %-23.4-24.6 95.0%  
Return on capital %-7.73.9 -196.0%  
Exports to sales %024.0 0.0%   
Imports to sales %017.5 0.0%   
Exports (fob) Rs mNA1,424 0.0%   
Imports (cif) Rs mNA1,040 0.0%   
Fx inflow Rs m9,8071,600 612.9%   
Fx outflow Rs m1,7891,131 158.1%   
Net fx Rs m8,019469 1,711.2%   
CASH FLOW
From Operations Rs m6841,180 58.0%  
From Investments Rs m6,302553 1,139.9%  
From Financial Activity Rs m-7,695-1,644 468.2%  
Net Cashflow Rs m-66490 -740.2%  

Share Holding

Indian Promoters % 74.5 74.5 100.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.3 0.6 383.3%  
FIIs % 7.7 1.3 592.3%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 23.6 65.3%  
Shareholders   67,757 10,259 660.5%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT With:   DIVIS LABORATORIES  GLENMARK PHARMA  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  FDC LTD.  

Compare WOCKHARDT With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Lower; Banking and Automobile Stocks Witness Selling(Closing)

After opening the day on a strong note, Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.

Related Views on News

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (3QFY19); Net Profit Down 80.6% (Quarterly Result Update)

Jan 29, 2019 | Updated on Jan 29, 2019

For the quarter ended December 2018, WOCKHARDT LTD. has posted a net profit of Rs 769 m (down 80.6% YoY). Sales on the other hand came in at Rs 10 bn (up 4.0% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

WOCKHARDT LTD. Announces Quarterly Results (2QFY19); Net Profit Down 158.2% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, WOCKHARDT LTD. has posted a net profit of Rs 228 m (down 158.2% YoY). Sales on the other hand came in at Rs 11 bn (up 10.1% YoY). Read on for a complete analysis of WOCKHARDT LTD.'s quarterly results.

More Views on News

Most Popular

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT SHARE PRICE


Apr 23, 2019 (Close)

TRACK WOCKHARDT

  • Track your investment in WOCKHARDT with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE WOCKHARDT WITH

MARKET STATS